TGFB1 and neoplasm: While its tumor-suppressive role is often observed in the early stages of cancer development, the inhibitory effects of Rapamycin may stem from TGFβ’s capacity to fuel tumor progression in later stages, by promoting angiogenesis, immune evasion and metastasis [51,52].